Treatment of hemangiomas of infancy. Dermatol Ther 2005;18(2):151-9
Date
06/15/2005Pubmed ID
15953144DOI
10.1111/j.1529-8019.2005.05018.xScopus ID
2-s2.0-21644431713 (requires institutional sign-in at Scopus site) 25 CitationsAbstract
Hemangiomas of infancy are the most common tumors of childhood. They are clinically heterogeneous and as such require individualized treatment plans. Although there are no Food and Drug Administration (FDA)-approved agents for treatment of hemangiomas of infancy, there are many widely used therapeutic options available. This review highlights the treatments currently in use and the factors that direct treatment.
Author List
Barrio VR, Drolet BAMESH terms used to index this publication - Major topics in bold
HemangiomaHumans
Infant, Newborn
Neoplasms, Vascular Tissue
